Using molecular profiled human tissue to accelerate drug discovery

Katherine A. Tarvin, George Sandusky

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The value of molecular profiled human tissue lies in its potential to improve the efficiency of drug discovery and development. The sequencing and profiling of human biospecimens across multiple omics dimensions provides layers of molecular information that can be used to enhance our knowledge of disease mechanisms to identify and prioritize novel drug targets and provide supportive biological evidence to support a therapeutic hypothesis. It is critical to control pre-analytical variables because the reproducibility and accuracy of molecular data generated by high-throughput technologies is dependent upon biospecimen quality. The scientific knowledge and technology developments gained in tissue banking research are transforming biospecimen collection and biostorage practices. These tissue banking advancements will improve specimen quality and utilization and, at the same time, reduce biobanking costs. Furthermore, well-annotated, high quality biospecimens will provide reliable, consistent gene expression data for target validation for drug discovery. Challenges in understanding the molecular signatures of biospecimens follow the challenges of human tissue acquisition. Sequencing and profiling high-throughput technologies generate heterogeneous, complex data sets that require sophisticated informatics tools for data storage and analysis. As tissue banking and informatics technologies improve and we gain deeper knowledge of the human genome and its functionality, we will see biomarker identification and target therapies brought about by the research performed on high quality biospecimens.

Original languageEnglish
Pages (from-to)1383-1387
Number of pages5
JournalExpert Opinion on Drug Discovery
Volume9
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

Tissue Banks
Drug Discovery
Informatics
Technology
Information Storage and Retrieval
Human Genome
Research
Biomarkers
Gene Expression
Costs and Cost Analysis
Therapeutics
Pharmaceutical Preparations

Keywords

  • Biobanking
  • Drug discovery
  • Gene expression
  • High quality biospecimens
  • Human tissues
  • Molecular profiling
  • Next generation technologies
  • Omics research

ASJC Scopus subject areas

  • Drug Discovery
  • Medicine(all)

Cite this

Using molecular profiled human tissue to accelerate drug discovery. / Tarvin, Katherine A.; Sandusky, George.

In: Expert Opinion on Drug Discovery, Vol. 9, No. 12, 01.12.2014, p. 1383-1387.

Research output: Contribution to journalArticle

@article{2df384e49bba4e9c9cc913832745b277,
title = "Using molecular profiled human tissue to accelerate drug discovery",
abstract = "The value of molecular profiled human tissue lies in its potential to improve the efficiency of drug discovery and development. The sequencing and profiling of human biospecimens across multiple omics dimensions provides layers of molecular information that can be used to enhance our knowledge of disease mechanisms to identify and prioritize novel drug targets and provide supportive biological evidence to support a therapeutic hypothesis. It is critical to control pre-analytical variables because the reproducibility and accuracy of molecular data generated by high-throughput technologies is dependent upon biospecimen quality. The scientific knowledge and technology developments gained in tissue banking research are transforming biospecimen collection and biostorage practices. These tissue banking advancements will improve specimen quality and utilization and, at the same time, reduce biobanking costs. Furthermore, well-annotated, high quality biospecimens will provide reliable, consistent gene expression data for target validation for drug discovery. Challenges in understanding the molecular signatures of biospecimens follow the challenges of human tissue acquisition. Sequencing and profiling high-throughput technologies generate heterogeneous, complex data sets that require sophisticated informatics tools for data storage and analysis. As tissue banking and informatics technologies improve and we gain deeper knowledge of the human genome and its functionality, we will see biomarker identification and target therapies brought about by the research performed on high quality biospecimens.",
keywords = "Biobanking, Drug discovery, Gene expression, High quality biospecimens, Human tissues, Molecular profiling, Next generation technologies, Omics research",
author = "Tarvin, {Katherine A.} and George Sandusky",
year = "2014",
month = "12",
day = "1",
doi = "10.1517/17460441.2014.959926",
language = "English",
volume = "9",
pages = "1383--1387",
journal = "Expert Opinion on Drug Discovery",
issn = "1746-0441",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Using molecular profiled human tissue to accelerate drug discovery

AU - Tarvin, Katherine A.

AU - Sandusky, George

PY - 2014/12/1

Y1 - 2014/12/1

N2 - The value of molecular profiled human tissue lies in its potential to improve the efficiency of drug discovery and development. The sequencing and profiling of human biospecimens across multiple omics dimensions provides layers of molecular information that can be used to enhance our knowledge of disease mechanisms to identify and prioritize novel drug targets and provide supportive biological evidence to support a therapeutic hypothesis. It is critical to control pre-analytical variables because the reproducibility and accuracy of molecular data generated by high-throughput technologies is dependent upon biospecimen quality. The scientific knowledge and technology developments gained in tissue banking research are transforming biospecimen collection and biostorage practices. These tissue banking advancements will improve specimen quality and utilization and, at the same time, reduce biobanking costs. Furthermore, well-annotated, high quality biospecimens will provide reliable, consistent gene expression data for target validation for drug discovery. Challenges in understanding the molecular signatures of biospecimens follow the challenges of human tissue acquisition. Sequencing and profiling high-throughput technologies generate heterogeneous, complex data sets that require sophisticated informatics tools for data storage and analysis. As tissue banking and informatics technologies improve and we gain deeper knowledge of the human genome and its functionality, we will see biomarker identification and target therapies brought about by the research performed on high quality biospecimens.

AB - The value of molecular profiled human tissue lies in its potential to improve the efficiency of drug discovery and development. The sequencing and profiling of human biospecimens across multiple omics dimensions provides layers of molecular information that can be used to enhance our knowledge of disease mechanisms to identify and prioritize novel drug targets and provide supportive biological evidence to support a therapeutic hypothesis. It is critical to control pre-analytical variables because the reproducibility and accuracy of molecular data generated by high-throughput technologies is dependent upon biospecimen quality. The scientific knowledge and technology developments gained in tissue banking research are transforming biospecimen collection and biostorage practices. These tissue banking advancements will improve specimen quality and utilization and, at the same time, reduce biobanking costs. Furthermore, well-annotated, high quality biospecimens will provide reliable, consistent gene expression data for target validation for drug discovery. Challenges in understanding the molecular signatures of biospecimens follow the challenges of human tissue acquisition. Sequencing and profiling high-throughput technologies generate heterogeneous, complex data sets that require sophisticated informatics tools for data storage and analysis. As tissue banking and informatics technologies improve and we gain deeper knowledge of the human genome and its functionality, we will see biomarker identification and target therapies brought about by the research performed on high quality biospecimens.

KW - Biobanking

KW - Drug discovery

KW - Gene expression

KW - High quality biospecimens

KW - Human tissues

KW - Molecular profiling

KW - Next generation technologies

KW - Omics research

UR - http://www.scopus.com/inward/record.url?scp=84912035042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912035042&partnerID=8YFLogxK

U2 - 10.1517/17460441.2014.959926

DO - 10.1517/17460441.2014.959926

M3 - Article

C2 - 25217252

AN - SCOPUS:84912035042

VL - 9

SP - 1383

EP - 1387

JO - Expert Opinion on Drug Discovery

JF - Expert Opinion on Drug Discovery

SN - 1746-0441

IS - 12

ER -